|
Market Cap (2-Jul) $356,619,552 (530th) |
Close (30-Jun) $0.315 |
Volume (30-Jun) 2,012,212 |
Shortsold (19-Jun) 27,150,697 (1.86%) (138th) |
|
52w High $0.415 |
52w Low $0.223 |
P/E 7.50 |
EPS -0.03 |
IMM released this announcement to the ASX on 13 September 2022, 8:14. The announcement is not marked as price sensitive, and is 2 page(s) in length and 210.91kb in size.
You can view all announcements from IMM and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMM was 0.846% short sold according to ASIC data. It was ranked the 233rd most shorted stock on the ASX. It is now ranked as the 138th most shorted stock on the ASX with 1.859% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from IMM | |
|---|---|
| Application for quotation of securities - IMM | 29 June 2023, 10:09 |
| US patent granted for Efti with PD-1 pathway inhibitor | 27 June 2023, 14:37 |
| Immutep completes underwritten retail entitlement offer | 27 June 2023, 8:16 |
| Immutep Appoints LAG-3 Pioneer Dr Frederic Triebel to Board | 13 September 2022, 8:14 |
| New investigator-initiated ph2 trial in Soft Tissue Sarcoma | 6 September 2022, 9:21 |
| Appendix 4E & 2022 Full Year Statutory Accounts | 31 August 2022, 17:35 |
| Japanese Patent Grant for efti, soluble LAG-3 with anti-PD-1 | 30 August 2022, 9:43 |
You must be logged in to post a reply.
